title: An open assessment of tenoxicam (Tilcotil) in the treatment of acute gout in general practice.
abstract: Twenty-nine patients presenting to their general practitioners with acute gout were treated with tenoxicam 40 mg daily for two days then 20 mg daily for five days. The treatment was well tolerated and 79% of participants responded to therapy. Side affects were minor with no patients withdrawing from the treatment course.
mesh_terms: D000208:Acute Disease; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D005194:Family Practice; D005260:Female; D006073:Gout / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010894:Piroxicam / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D010894:Piroxicam; C032801:tenoxicam